Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease
Bernardo Casso-Chapa(The University of Texas MD Anderson Cancer Center), Jun‐ichi Abe(The University of Texas MD Anderson Cancer Center), Nerea González(The University of Texas MD Anderson Cancer Center), Jared K. Burks(The University of Texas MD Anderson Cancer Center), James L. Kirkland(Cedars-Sinai Medical Center), Isabella M. Grumbach(University of Iowa), Jonghae Lee(The University of Texas MD Anderson Cancer Center), Sunil Krishnan(Smith Family), Anita Deswal(The University of Texas MD Anderson Cancer Center), Nicolas L. Palaskas(The University of Texas MD Anderson Cancer Center), Cezar Iliescu(The University of Texas MD Anderson Cancer Center), Abhishek Jain(Boston Children's Hospital), Laurent Yvan‐Charvet(Inserm), Khanh Chau(Houston Methodist), Eduardo N. Chini(Mayo Clinic in Arizona), Nordin M.J. Hanssen(Foundation Centrum '45), Menno P.J. de Winther(Amsterdam University Medical Centers), O.N. Hoang(The University of Texas MD Anderson Cancer Center), Paul S. Brookes(University of Rochester Medical Center), Philip L. Lorenzi(City Of Hope National Medical Center), Venkata Subrahman K Samanthapudi(The University of Texas MD Anderson Cancer Center), Kevin T. Nead(The University of Texas MD Anderson Cancer Center), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Erin H. Seeley(The University of Texas at Austin), Keila Carolina Ostos Mendoza(The University of Texas MD Anderson Cancer Center), Gilbert Mejia(The University of Texas MD Anderson Cancer Center), Sivareddy Kotla(University of Tennessee Health Science Center), Guangyu Wang(Tongji University), Nhat‐Tu Le(Houston Methodist), Syed Wamique Yusuf(The University of Texas MD Anderson Cancer Center), Xander H.T. Wehrens(Baylor College of Medicine), Lydia P. Eutsey(The University of Texas MD Anderson Cancer Center), Keri Schadler(The University of Texas MD Anderson Cancer Center)
Cited by 3
Related Papers
The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
|Aging Cell|2015|2.4k
Estimated Projection of US Cancer Incidence and Death to 2040
|JAMA Network Open|2021|1.3k
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
|EBioMedicine|2019|1.2k
Cellular senescence and senolytics: the path to the clinic
|Nature Medicine|2022|1k